Journal article
Cost Effectiveness of Leukotriene Receptor Antagonists versus Inhaled Corticosteroids for Initial Asthma Controller Therapy
Authors
Wilson ECF; Sims EJ; Musgrave SD; Shepstone L; Blyth A; Murdoch J; Mugford HM; Juniper EF; Ayres JG; Wolfe S
Journal
PharmacoEconomics, Vol. 28, No. 7, pp. 585–595
Publisher
Springer Science and Business Media LLC
Publication Date
July 1, 2010
DOI
10.2165/11537550-000000000-00000
ISSN
1170-7690
Medical Subject Headings (MeSH)
Administration, InhalationAdolescentAdrenal Cortex HormonesAdrenergic beta-2 Receptor AgonistsAdrenergic beta-AgonistsAdultAgedAged, 80 and overAsthmaChildCost-Benefit AnalysisDelayed-Action PreparationsDrug Therapy, CombinationHumansLeukotriene AntagonistsMiddle AgedQuality-Adjusted Life YearsSurveys and QuestionnairesTreatment OutcomeUnited KingdomYoung Adult